NCT03744624 Application of 3D Printing in Laparoscopic Surgery of Liver Tumors Status UNKNOWN Phase NA
NCT03739164 Tampa Associating Microwave Liver Ablation With Portal Vein Ligation for Staged Hepatectomy (TAMLAPS) Status UNKNOWN Phase N/A
NCT03723304 The Intention-to-treat Effect of Bridge Therapies in the Setting of Milan-in Patients Status COMPLETED Phase N/A
NCT03668418 Xenotransplantation of Primary Cancer Samples in Zebrafish Embryos Status UNKNOWN Phase N/A
NCT03662204 Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors Status COMPLETED Phase N/A
NCT03620916 Comparison of Intrathecal and Intravenous Analgesia in Patients Undergoing Liver Resection Status UNKNOWN Phase NA
NCT03602079 Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene Status COMPLETED Phase PHASE1/PHASE2
NCT03595345 A Worldwide Score for Hepatocellular Cancer and Liver Transplantation Status COMPLETED Phase N/A
NCT03592706 Autologous Immune Killer Cells to Treat Liver Cancer Patients as an Adjunct Therapy Status UNKNOWN Phase PHASE2/PHASE3
NCT03552718 QUILT-2.025 NANT Neoepitope Yeast Vaccine (YE-NEO-001): Adjuvant Immunotherapy Using a Personalized Neoepitope Yeast-Based Vaccine To Induce T-Cell Responses In Subjects W/ Previously Treated Cancers. Status COMPLETED Phase PHASE1
NCT03516695 RadioEmbolization for the ADvancement of Y90 Glass Microspheres Registry Status TERMINATED Phase N/A
NCT03515252 Study of Autologous Immune Killer Cells in Patients With Late Stage Hepatocellular Carcinoma or Lung Cancer Status COMPLETED Phase PHASE1
NCT03475966 Improving Outcomes in Cancer Patients With a Nutritional and Physical Conditioning Prehabilitation Program Status UNKNOWN Phase NA
NCT03408665 Stereotactic Body Radiation Therapy (SBRT) Efficiency and Toxicity in Liver Cancer Status ACTIVE_NOT_RECRUITING Phase NA
NCT03405909 Standardized CEUS Algorithms for Diagnosis of HCC - Prospective German Multicenter Study Status COMPLETED Phase N/A
NCT03383458 A Study of Nivolumab in Participants With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or Ablation Status ACTIVE_NOT_RECRUITING Phase PHASE3